Access Vascular Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $19.9M
Latest Deal Amount
  • Investors
  • 2

Access Vascular General Information

Description

Developer of vascular access devices designed to address the most common and costly complications in intravenous therapy. The company's devices use novel hydrogel material and not a coating or additive that has been shown to reduce thrombus accumulation and may also reduce infection and phlebitis which prevents the accumulation of blood components that can lead to blood clots and reduces thrombus cascade, enabling patients to get vessel salvage, reduced circulatory compromise and increased catheter dwell time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 175 Middlesex Turnpike
  • Suite 1A
  • Bedford, MA 01730
  • United States
+1 (781) 000-0000

Access Vascular Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Access Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 03-Mar-2021 $19.9M 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A1) 06-Sep-2019 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 23-Aug-2018 $3M $6.77M 0000 Completed Product Development
1. Seed Round 16-Aug-2017 $3.77M $3.77M 000.00 Completed Startup
To view Access Vascular’s complete valuation and funding history, request access »

Access Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed B 0,000,000 00.000000 00.0 00.0 00 00.0 00.00
Seed A 1,800,000 $0.000100 $0.29 $0.29 1x $0.29 3.03%
Seed 1,200,000 $0.000100 $0.21 $0.21 1x $0.21 2.02%
To view Access Vascular’s complete cap table history, request access »

Access Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of vascular access devices designed to address the most common and costly complications in intravenous therapy
Therapeutic Devices
Bedford, MA
20 As of 2021
000.00
00.00 0000-00-00
00000000000 000.00

0000000

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
00000000000 0000000
Largo, FL
00 As of 0000
00.000
000000000000 00.000

00000

o consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
00000000000 0000000
Redwood City, CA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Access Vascular Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioDerm Private Equity-Backed Largo, FL 00 00.000 000000000000 00.000
00000 Formerly VC-backed Redwood City, CA 000 00000 00000000000 00000
0000 Formerly VC-backed Bothell, WA 00 00000 000000&0 00000
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 000000000 - 00000
0000000 0000000000 Corporation Irvine, CA 00000 000 000000000 000
You’re viewing 5 of 15 competitors. Get the full list »

Access Vascular Executive Team (2)

Name Title Board Seat Contact Info
James Biggins Founder, Chief Executive Officer, President & Board Member
Bradley Rosenblum Fractional Chief Financial Officer
To view Access Vascular’s complete executive team members history, request access »

Access Vascular Board Members (7)

Name Representing Role Since
Alexandra MacLean TVM Capital Life Science Board Member 000 0000
Brent Ratz Self Board Member 000 0000
James Biggins Access Vascular Founder, Chief Executive Officer, President & Board Member 000 0000
Joseph Pellegrino Jr. Self Board Member 000 0000
Luc Marengère Ph.D TVM Capital Life Science Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Access Vascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Access Vascular Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TVM Capital Life Science Venture Capital Minority 000 0000 000000 0
AngelMD Angel Group Minority 000 0000 000000 0
To view Access Vascular’s complete investors history, request access »